Assistance Listing 93.393
Cancer Cause and Prevention Research
Follow the funding history and Grants.gov notices that share Assistance Listing 93.393.
Historical prime grant obligations
| Assistance Listing | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| 93.393 · Cancer Cause and Prevention Research | $722,670,654.15 | $730,757,626.82 | $803,105,091.64 |
Filter USAspending award search by Assistance Listing 93.393 to inspect individual awards.
Notices for this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) PAR-25-096 · National Institutes of Health · November 17, 2026 · 93.121, 93.172, 93.393, 93.866
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-24-214 · National Institutes of Health · January 7, 2027 · 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) PAR-25-167 · National Institutes of Health · January 7, 2027 · 93.393, 93.399
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) PAR-25-069 · National Institutes of Health · January 7, 2027 · 93.393
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) PAR-25-070 · National Institutes of Health · January 7, 2027 · 93.393
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) PAR-25-081 · National Institutes of Health · January 7, 2027 · 93.393, 93.394, 93.395, 93.399
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) RFA-NS-25-023 · National Institutes of Health · January 15, 2027 · 93.121, 93.213, 93.273, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) RFA-CA-28-013 · National Institutes of Health · February 9, 2027 · 93.393, 93.396, 93.399
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 · National Institutes of Health · April 5, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 · National Institutes of Health · April 5, 2027 · 93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) PAR-28-057 · National Institutes of Health · May 25, 2027 · 93.393
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) PAR-25-210 · National Institutes of Health · June 2, 2027 · 93.121, 93.213, 93.313, 93.393, 93.866
- Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) PAR-25-211 · National Institutes of Health · June 2, 2027 · 93.121, 93.213, 93.313, 93.393, 93.866
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 · National Institutes of Health · July 12, 2027 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 · National Institutes of Health · July 17, 2027 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.351, 93.352, 93.353, 93.361, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-25-080 · National Institutes of Health · September 7, 2027 · 93.113, 93.121, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.859, 93.866, 93.867, 93.879
- Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) PAR-25-325 · National Institutes of Health · September 10, 2027 · 93.393
- Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) PAR-25-248 · National Institutes of Health · October 8, 2027 · 93.393
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) RFA-CA-27-019 · National Institutes of Health · October 19, 2027 · 93.393, 93.394, 93.395, 93.396, 93.399
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-27-078 · National Institutes of Health · October 25, 2027 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.393, 93.394, 93.395, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-25-244 · National Institutes of Health · November 16, 2027 · 93.393
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) PAR-25-134 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) PAR-25-148 · National Institutes of Health · January 7, 2028 · 93.172, 93.173, 93.233, 93.242, 93.273, 93.279, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.865, 93.866, 93.867
- Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) PAR-24-273 · National Institutes of Health · January 7, 2028 · 93.307, 93.361, 93.393, 93.866
- Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) PAR-25-243 · National Institutes of Health · January 7, 2028 · 93.393
- Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) PAR-25-145 · National Institutes of Health · January 7, 2028 · 93.393
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-25-346 · National Institutes of Health · January 7, 2028 · 93.121, 93.393, 93.394, 93.395, 93.396, 93.399
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) PAR-25-321 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.399
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) PAR-25-175 · National Institutes of Health · January 7, 2028 · 93.393, 93.394, 93.395
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-25-043 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) PAR-25-044 · National Institutes of Health · January 7, 2028 · 93.393, 93.396, 93.399
- Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) PA-25-172 · National Institutes of Health · January 7, 2028 · 93.393, 93.399
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) PA-25-304 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) PA-25-306 · National Institutes of Health · January 7, 2028 · 93.113, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.865, 93.866, 93.867, 93.879
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-25-301 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.143, 93.172, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-25-298 · National Institutes of Health · January 7, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.853, 93.855, 93.865, 93.866, 93.867
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) PAR-25-292 · National Institutes of Health · January 7, 2028 · 93.242, 93.279, 93.307, 93.361, 93.393, 93.396, 93.399, 93.866
- Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 · National Institutes of Health · August 25, 2028 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.286, 93.307, 93.313, 93.351, 93.361, 93.393, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.867, 93.879
- Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) PA-25-253 · National Institutes of Health · September 7, 2028 · 93.393, 93.399
- Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) PAR-25-324 · National Institutes of Health · September 7, 2028 · 93.393, 93.394, 93.395, 93.396, 93.397, 93.399
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 · National Institutes of Health · November 30, 2028 · 93.113, 93.121, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) PA-27-101 · National Institutes of Health · April 5, 2029 · 93.233, 93.242, 93.273, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 · National Institutes of Health · April 5, 2029 · 93.113, 93.121, 93.143, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.307, 93.313, 93.350, 93.351, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 · National Institutes of Health · May 7, 2029 · 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.310, 93.313, 93.350, 93.351, 93.361, 93.372, 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879, 93.989
- Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 · National Institutes of Health · May 25, 2029 · 93.121, 93.233, 93.242, 93.279, 93.307, 93.310, 93.361, 93.393, 93.394, 93.395, 93.396, 93.837, 93.838, 93.839, 93.840, 93.847, 93.855, 93.865, 93.866, 93.989
- NIH Research Program Projects (Parent P01 Clinical Trial Optional) PA-27-061 · National Institutes of Health · May 25, 2029 · 93.113, 93.172, 93.233, 93.273, 93.279, 93.307, 93.313, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.855, 93.866, 93.879
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 · National Institutes of Health · June 20, 2029 · 93.121, 93.233, 93.242, 93.273, 93.279, 93.307, 93.310, 93.313, 93.361, 93.393, 93.394, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.855, 93.865, 93.866, 93.879
- Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-27-072 · National Institutes of Health · July 5, 2029 · 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.865, 93.867
- Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) PAR-27-073 · National Institutes of Health · July 5, 2029 · 93.393
- Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) PAR-28-014 · National Institutes of Health · October 11, 2029 · 93.113, 93.393
- Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) PAR-27-090 · National Institutes of Health · November 5, 2029 · 93.242, 93.307, 93.361, 93.393, 93.853, 93.865, 93.866
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) PAR-28-056 · National Institutes of Health · November 5, 2029 · 93.393
Source scope
How the records were joined
Grants.gov postings were checked November 10, 2026. Notice details come from the official extract dated November 10, 2026 and the Grants.gov detail service where newer information was available. Deadline comparisons use the same opportunity ID, number and agency across notice versions. A revised date can reflect a new filing cycle. Read the current announcement and package for the deadline that applies to you.
USAspending history groups signed prime grant and cooperative-agreement obligations by exact Assistance Listing and fiscal year. Amendments can reduce a total. An obligation is a commitment. These figures cover the program’s reported transactions across awards and say nothing about available funds or the chance of an award under a particular notice. Missing program-year rows are shown as unavailable. Program figures should be read separately when a notice lists several programs.
This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.
Grants.gov extracts · Treasury data guide · Treasury API · Download the America.co snapshot